Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update

NEXT STORY
Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Efgartigimod in Pemphigus
PREV STORY
Global Neurological Therapies Market Research Report 2021: Competitive Landscape and Pipeline Analysis Focusing Specifically on Therapeutic Interventions for Neurodegenerative Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Mersana Presents Interim Phase 1 Data for XMT-1536 at the 2019 American Society of Clinical Oncology Annual Meeting

author_avatar
NASDAQ Market News

XWPharma Names Michael M. Morrissey, PhD to Board of Directors

author_avatar
NASDAQ Market News